Selected article for: "MD simulation and molecular dynamic"
Author: Sur, Vishma Pratap; Sen, Madhab Kumar; Komrskova, Katerina
Title: In Silico Identification and Validation of Organic Triazole Based Ligands as Potential Inhibitory Drug Compounds of SARS-CoV-2 Main Protease
  • Cord-id: 9r6dt6b3
  • Document date: 2021_10_14
    • ID: 9r6dt6b3
    Snippet: The SARS-CoV-2 virus is highly contagious to humans and has caused a pandemic of global proportions. Despite worldwide research efforts, efficient targeted therapies against the virus are still lacking. With the ready availability of the macromolecular structures of coronavirus and its known variants, the search for anti-SARS-CoV-2 therapeutics through in silico analysis has become a highly promising field of research. In this study, we investigate the inhibiting potentialities of triazole-based
    Document: The SARS-CoV-2 virus is highly contagious to humans and has caused a pandemic of global proportions. Despite worldwide research efforts, efficient targeted therapies against the virus are still lacking. With the ready availability of the macromolecular structures of coronavirus and its known variants, the search for anti-SARS-CoV-2 therapeutics through in silico analysis has become a highly promising field of research. In this study, we investigate the inhibiting potentialities of triazole-based compounds against the SARS-CoV-2 main protease (M(pro)). The SARS-CoV-2 main protease (M(pro)) is known to play a prominent role in the processing of polyproteins that are translated from the viral RNA. Compounds were pre-screened from 171 candidates (collected from the DrugBank database). The results showed that four candidates (Bemcentinib, Bisoctrizole, PYIITM, and NIPFC) had high binding affinity values and had the potential to interrupt the main protease (M(pro)) activities of the SARS-CoV-2 virus. The pharmacokinetic parameters of these candidates were assessed and through molecular dynamic (MD) simulation their stability, interaction, and conformation were analyzed. In summary, this study identified the most suitable compounds for targeting Mpro, and we recommend using these compounds as potential drug molecules against SARS-CoV-2 after follow up studies.

    Search related documents:
    Co phrase search for related documents
    • accessible area and admet analysis: 1
    • accessible area and admet toxicity: 1
    • accessible solvent and active site: 1, 2, 3
    • accessible solvent and admet analysis: 1, 2
    • accessible solvent and admet toxicity: 1
    • accessible surface area and active site: 1
    • accessible surface area and admet analysis: 1
    • accessible surface area and admet toxicity: 1
    • active site and acute toxicity: 1
    • active site and additional binding interaction: 1
    • active site and admet analysis: 1, 2, 3, 4, 5, 6
    • active site and admet analysis drug likeness: 1, 2
    • active site and admet toxicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • active site and admet toxicity excretion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active site and admet toxicity excretion metabolism: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active site and admet toxicity excretion metabolism distribution: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active site residue and admet analysis: 1
    • acute toxicity and admet analysis: 1
    • acute toxicity and admet toxicity: 1